Abiopharma

PICARD MEDICAL, INC. Issues Letter to Shareholders

UnitedHealthcare Eliminates Nearly Two-Thirds of Prior Authorization Requirements for Pediatric Care

REGO Introduces Flexible Family Wallet Implementation Models for Financial Institutions

Church & Dwight Announces Miss Mouth’s Messy Eater® Brand Acquisition

Genesco Inc. Reports Fiscal 2027 First Quarter Results

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC

The Buckle, Inc. Reports First Quarter Net Income

Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026

FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)

Net Asset Value(s)